Cargando…

Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up

OBJECTIVE: This study was aimed at analyzing the efficacy and safety of an injectable form of chlorogenic acid (CGA) in patients with recurrent high-grade glioma after standard of care treatments, through a first-in-human, open-label, dose-escalation phase I trial. METHODS: A total of 26 eligible pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Zhuang, Li, Shan, Kang, Xun, Deng, Jing, Yang, Huarong, Chen, Feng, Jiang, Jiandong, Zhang, Jie, Li, Wenbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291982/ https://www.ncbi.nlm.nih.gov/pubmed/37366368 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0762

Ejemplares similares

A phase I dose-escalation study of SYHA1813, a VEGFR and CSF1R inhibitor, in patients with recurrent High-Grade Gliomas or Advanced Solid Tumors
por: Kang, Zhuang, et al.
Publicado: (2023)

Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype
por: Xue, Nina, et al.
Publicado: (2017)

Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas
por: Wang, Joshua L., et al.
Publicado: (2020)

Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
por: Franceschi, E, et al.
Publicado: (2004)

Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma
por: Vairy, Stephanie, et al.
Publicado: (2020)

TIPS-12 PHASE I CLINICAL STUDY OF TG02 CAPSULE IN THE TREATMENT OF RECURRENT HIGH-GRADE GLIOMAS WITH FAILED TMZ TREATMENT
por: Guo, Chengcheng, et al.
Publicado: (2023)

Stereotactic Radiosurgery for the Treatment of Recurrent High-grade Gliomas: Long-term Follow-up
por: Sallabanda, Kita, et al.
Publicado: (2019)

Re-irradiation alternatives for recurrent high-grade glioma
por: Dong, Yuanli, et al.
Publicado: (2016)

Features and therapeutic potential of T-cell receptors in high-grade glioma
por: Zhang, Jie-Lin, et al.
Publicado: (2019)

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
por: Akiyama, Yasuto, et al.
Publicado: (2012)

Phase I Study of High-Dose l-Methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH Wild-Type High-Grade Glioma
por: Salas, Lucas A., et al.
Publicado: (2022)

A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.
por: Bleehen, N. M., et al.
Publicado: (1995)

Reverse swing‐M, phase 1 study of repurposing mebendazole in recurrent high‐grade glioma
por: Patil, Vijay M., et al.
Publicado: (2020)

Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas
por: Gregucci, Fabiana, et al.
Publicado: (2022)

TIPS-13 A PHASE II STUDY OF NEOADJUVANT CAMRELIZUMAB AND APATINIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS
por: Guo, Chengcheng, et al.
Publicado: (2023)

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
por: Osman, Mohammed A
Publicado: (2014)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Electrolytic Chlorogen
por: Macworth, N. W.
Publicado: (1922)

Electrolytic Chlorogen
por: Hutchinson, C. W.
Publicado: (1923)

Electrolytic Chlorogen
por: Stewart, A. D.
Publicado: (1923)

Chlorogenic acid and its role in biological functions: an up to date
por: Kim, Jae Kwang, et al.
Publicado: (2019)

Association between dietary minerals and glioma: A case-control study based on Chinese population
por: Zhang, Weichunbai, et al.
Publicado: (2023)

Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas
por: Wong, Eric T., et al.
Publicado: (2016)

Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPG
por: Tinkle, Christopher L, et al.
Publicado: (2021)

Chlorogenic acid in the oxidative stress injury triggered by Shuang-Huang-Lian injection
por: Du, Wen-Yuan, et al.
Publicado: (2018)

EPCT-01. PHASE I STUDY OF DAY101 (TAK580) IN CHILDREN AND YOUNG ADULTS WITH RADIOGRAPHICALLY RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA (LGG)
por: Wright, Karen, et al.
Publicado: (2020)

Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
por: Leblond, Pierre, et al.
Publicado: (2023)

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy
por: Teng, Chubei, et al.
Publicado: (2022)

Carbon Ion Beam Reirradiation in Recurrent High-Grade Glioma
por: Eberle, Fabian, et al.
Publicado: (2020)

Decisional needs of patients with recurrent high-grade glioma and their families
por: Sorensen von Essen, Helle, et al.
Publicado: (2022)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma
por: Ghiaseddin, Ashley, et al.
Publicado: (2017)

Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy
por: Zhou, Xiaofeng, et al.
Publicado: (2016)

Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas
por: Zhang, Ming, et al.
Publicado: (2022)

Healthy and Unhealthy Plant-Based Diets and Glioma in the Chinese Population
por: Zhang, Weichunbai, et al.
Publicado: (2023)

Protective Effects of Chlorogenic Acid against Experimental Reflux Esophagitis in Rats
por: Kang, Jung-Woo, et al.
Publicado: (2014)

Chlorogenic Acid Improves Quality of Chilled Ram Sperm by Mitigating Oxidative Stress
por: Wang, Yanhu, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte Ratio and Its Changes are Related to Grade II–IV Glioma Recurrence
por: Ma, Lianghua, et al.
Publicado: (2020)

Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

(11)C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
por: Bag, Asim K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qgitnp564gv5akpn6okdh8rvtk